Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
16.86
-0.97 (-5.44%)
At close: Sep 11, 2026, 4:00 PM EDT
16.53
-0.33 (-1.96%)
After-hours: Sep 11, 2026, 7:43 PM EDT
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $279.56 million as of September 11, 2026. Its market cap has increased by 262.22% in one year.
Market Cap
279.56M
Enterprise Value
126.00M
1-Year Change
262.22%
Ranking
Category
Stock Price
$16.86
ChartMarket Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $346.92M to $279.56M, a decrease of -19.42%. That is a compound annual growth rate of -2.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 279.56M | 183.62% |
| Dec 31, 2025 | 98.57M | -35.03% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 293.08M |
| Clinuvel Pharmaceuticals | 290.78M |
| Fulcrum Therapeutics | 289.93M |
| YD Bio | 281.28M |
| Fate Therapeutics | 276.79M |
| Immuneering | 276.26M |
| AC Immune | 274.42M |
| Bicycle Therapeutics | 270.17M |